Jing Xu, Jiefang Huang, Qidong Xue, Huilin Xu, Jie Mi, Tongyu Zhang, Yiwen Guo, Ruijie Liu, Ming Chang
8 min
Flaxseed oil production generates significant quantities of flaxseed meal as a byproduct, which typically contains over 98% of the plant's cyclolinopeptides (CLs). These cyclic peptides are known for their bioactivity but are currently discarded. This study investigated whether a methanol-K2HPO4 aqueous two-phase extraction (ATPE) system could efficiently recover these peptides and whether the recovered CLs—specifically the predominant monomer CLA—could protect human dermal fibroblasts (HSFs) against hydrogen peroxide (H2O2)-induced senescence.
Researchers optimized the ATPE process by systematically varying K2HPO4 concentration, methanol content, feed-to-liquid ratio, and pH. The resulting cyclolinopeptide mixture (CLMIX) and the isolated CLA monomer were then tested in a H2O2-induced oxidative stress model. Cellular senescence was assessed through β-galactosidase activity, cell viability (MTT assay), and the regulation of apoptosis-related markers (BCL2, BAX) and collagen-degrading enzymes (MMP-1, MMP-3) via quantitative PCR and flow cytometry.
The optimized ATPE system successfully recovered 79% of flaxseed CLs. In senescent HSF models, both the CL mixture and the CLA monomer significantly suppressed senescence-associated β-galactosidase activity and decreased intracellular reactive oxygen species (ROS). Mechanistically, the CLA monomer mitigated apoptosis by upregulating the anti-apoptotic protein BCL2 and downregulating the pro-apoptotic protein BAX. Furthermore, both treatments reduced the expression of matrix metalloproteinases (MMP-1/MMP-3), suggesting a protective effect against collagen degradation associated with skin aging.
This research provides a scalable, eco-friendly method to valorize industrial flaxseed waste into high-value, food-grade ingredients. By demonstrating that specific cyclic peptides can act as potent antioxidants and anti-aging agents, the study highlights a sustainable path for developing functional foods or dermatological nutraceuticals from agricultural byproducts that are otherwise treated as waste.
Cyclolinopeptides (CLs), a class of cyclic peptides derived from flaxseed ( Linum usitatissimum L .), exhibit significant bioactivities. However, over 98% of CLs are discarded during flaxseed oil refining. This study hypothesized that an optimized methanol-K₂HPO₄ aqueous two-phase extraction (ATPE) system could efficiently recover CLs from flaxseed meal, and that these peptides might exhibit significant cellular protective effects against oxidative stress, underscoring their valorization potential. The ATPE conditions were optimized (14% K₂HPO₄, 44% methanol, feed-to-liquid ratio 1,30 w /w, pH 8.7), achieving a recovery rate of approximately 79%. Subsequently, the anti-senescence potential of CLs was systematically evaluated using an H 2 O 2 -induced senescence model in human dermal fibroblasts (HSFs). Results demonstrated that both the CL mixture (CLMIX, 120 μg/mL) and its predominant monomer CLA (20 μg/mL) significantly suppressed senescence-associated β-galactosidase (SA-β-gal) activity, inhibited excessive reactive oxygen species (ROS) generation, and attenuated apoptosis by upregulating BCL2 (B-cell lymphoma 2) and downregulating BAX (BCL2-associated X protein) expression. Furthermore, CLMIX and CLA mitigated collagen degradation via downregulation of MMP-1/MMP-3. Mechanistically, CLA counteracted oxidative stress-driven apoptosis by modulating the BCL2/BAX axis. These findings suggest that CLs, particularly CLA, could serve as functional food-grade ingredients with antioxidant and anti-senescence properties, enabling valorization of flaxseed processing waste. • The optimized ATPE system recovered 79% of flaxseed cyclolinopeptides. • CLA attenuated senescence by modulating the BCL2/BAX apoptotic pathway. • CLs demonstrated antioxidant and anti-aging activities in flaxseed byproducts.
Sam: Does the recovery number tell us how much would survive a whole industrial process?
Alex: No. It describes the optimized two-phase extraction stage. The workflow first defatted meal with hexane and made a crude extract using ethanol. After separation, the recovered fraction underwent solvent removal, washing, and freeze-drying. This isn't a demonstrated factory-wide recovery or a solvent-free process.
Sam: Once they had that fraction, how clean was it? That matters when attributing a biological effect to peptides.
Alex: The batch used in cells was about seventy-three percent cyclic peptides. The authors call it the cyclolinopeptide mixture; we'll call it the mixture. It's enriched, not chemically pure, so its effects can't automatically be assigned to one molecule.
Sam: Let's move to the biology. What exactly did they mean by protecting skin cells from aging?
Alex: They used human dermal fibroblasts, connective-tissue cells that help maintain skin structure. Hydrogen peroxide produced oxidative stress and a senescence-like state. Senescence means lasting cell-cycle arrest, but this induced model isn't the same as skin aging in a person.
Sam: If peroxide simply kills the cells, a survival result could be mistaken for an aging result. How did they approach that distinction?
Alex: They selected a peroxide exposure that increased senescence-associated staining while preserving most cell viability. They then examined several outcomes: viability, senescence markers, reactive oxygen species—the chemically reactive molecules associated with oxidative stress—and apoptosis, or programmed cell death.
Sam: Those are related outcomes, but they're not interchangeable. What did the recovered mixture actually improve?
Alex: At a selected dose of one hundred twenty micrograms per milliliter, it improved the cell-viability readout and reduced senescence-marker messenger RNA. It also reduced the oxidative-stress signal and was reported to reduce apoptosis relative to peroxide-treated cells without peptides. Higher mixture concentrations inhibited viability, so more wasn't necessarily better.
Sam: The paper also discusses collagen. Did they measure preserved collagen, or something upstream of it?
Alex: The detailed results show reduced messenger RNA for enzymes involved in collagen degradation. That supports a possible reduction in collagen-degrading pathways. It doesn't directly establish preserved collagen or improved skin elasticity.
Sam: Why move from that mixture to a single peptide? Was the aim to identify the active component?
Alex: They examined CLA, described as the most abundant flaxseed cyclolinopeptide. A defined molecule makes mechanistic interpretation more consistent. But there's a sourcing distinction: the recovered mixture came from their extraction, while the CLA used here was supplied separately.
Sam: So the CLA experiments don't show that their extraction produced a purified single ingredient. They test whether a known component can reproduce the mixture's protective pattern.
Alex: At twenty micrograms per milliliter, CLA improved viability and reduced senescence-associated staining and marker expression. It also reduced the intracellular reactive-oxygen signal by approximately forty percent in the stressed-cell model. Those findings support protective activity under these laboratory conditions.
Sam: The proposed mechanism involves cell-death regulation. What evidence connects the peptide to that pathway, rather than simply showing healthier cells?
Alex: They measured messenger RNA for opposing regulators of apoptosis. BCL2 is anti-apoptotic; BAX promotes apoptosis. CLA shifted expression toward more BCL2 and less BAX, alongside reduced cell death. The authors interpret that as a plausible protective pathway.
Sam: But messenger RNA doesn't establish protein activity. Do they show that this pathway is necessary for the protective effect?
Alex: The reported evidence doesn't establish necessity. The discussion explicitly says protein-level confirmation is needed. It also proposes a possible structural interaction with BAX, but identifies that as a hypothesis requiring validation, not a demonstrated binding mechanism.
Sam: How much replication sits underneath these effects? Several different assays can still come from a narrow experimental base.
Alex: For the reactive-oxygen assay, the methods report three independent biological replicates from separate cell thaws. The viability assay used replicate wells within one run. Those wells provide technical replication, not independent biological samples. My reading is promising exploratory evidence, not a broad validation.
Sam: And does enriching the peptides actually improve biological performance over the starting extract? That seems central to the commercial argument.
Alex: The authors acknowledge they didn't directly compare biological efficacy with crude flaxseed extract. They also call for comparisons with conventional extraction methods. So the study shows an enriched fraction retains activity, not that this process delivers superior activity or industrial economics.
Sam: With those boundaries, who should read the full document, and where should they start?
Alex: Researchers recovering food-derived peptides should start with the extraction-optimization results and the discussion of missing process comparisons. Cellular-aging researchers should read the CLA mechanism section alongside the replication details. For food applications, the authors still identify bioavailability, in vivo efficacy, long-term safety, and formulation compatibility as unresolved.
Sam: And what's the line everyone else should carry away?
Alex: Recovering useful molecules from waste is a process result; showing they help people is a separate test.
Sam: Thanks for listening.